HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Digital Health

Set Alert for Digital Health

UK Product Approvals: J&J Expands Sudafed And Nicorette Offerings

The UK's MHRA has approved the Rx-to-OTC switch of J&J's Sudafed Plus nasal spray (xylometazoline hydrochloride/dexpanthenol) and given the green light for the company to add new pack sizes to its Nicorette QuickMist and QuickMist Smart Track products.

Prescription To OTC Switch Launches

European Health Crisis Driving Consumers Towards Self-Care – Stada Report

European consumers are increasingly turning towards self-care options, research by Stada Arzneimittel shows. Especially in the areas of stress, sleep and mental health, they are seeking out alternatives to conventional medicine, such as dietary supplements, and support from new health technologies, like digital health apps.

Europe Health

Less Than Four Weeks Remain To Enter The OTC Marketing Awards 2022

Entries to the OTC Marketing Awards are coming in thick and fast from industry players large and small across the 15 categories. With the entry deadline fast approaching on 29 August, don't miss out on your chance to win a prestigious trophy. 

Ad Campaigns Innovation

Over The Counter 26 July 2022: Global Self-Care Trends With J&J Self-Care R&D Lead Adam Ricciardone

In this episode, HBW Insight speaks to Johnson & Johnson Self-Care R&D lead Adam Ricciardone about four macro trends the company is observing worldwide: total wellness, sustainability, demographic shifts and the “techceleration” of self-care. Ricciardone talks about J&J's latest self-care technologies and why non-western countries, particularly in Asia, are quicker to adopt new consumer healthcare trends. 

International North America

US Proposed Rule For OTC Hearing Aid Access Excites Eargo – Across Industry, Not So Much

CEO of direct-to-consumer hearing aid manufacturer Eargo says an OTC category for hearing aids would improve the quality of life for many consumers with hearing loss.

FDA OTC Devices

IQVIA Consumer Health: Brands Can Beat Inflation, But Only If OTC Firms Raise Their Game

Investments in digitalization, real world evidence and Rx-to-OTC switch can all help OTC companies thrive in a difficult global economic environment, argue IQVIA Consumer Health experts in a recent webinar.

International Health

Digital Home-Testing Is The Future, Says Bloom Diagnostics Co-Founder Angelica Kohlmann

With its lateral flow at-home tests for ferritin, thyroid function and ovarian reserves, Swiss medtech firm Bloom Diagnostics thinks it has seen the future of consumer healthcare. HBW Insight speaks to co-founder and board chair Angelica Kohlmann about the firm's Bloom Lab technology and forward-looking plans, including a possible US launch. 

Wellness Artificial Intelligence

AESGP Annual Meeting, Day 2 (Part 2): Can Regulation Be A Catalyst For Innovation?

Regulation should be seen as a spur to creativity rather than a burden, suggest panellists during the second session of the AESGP's 58th Annual Meeting in Madrid, Spain. Sanofi Consumer Healthcare boss Julie van Ongevalle also makes the case for electronic patient information leaflets as a way to learn from the pandemic, which she describes as the greatest constraint the world has experienced in recent history.

Europe Health
See All
UsernamePublicRestriction

Register